China Universal Asset Management Co., Ltd. Biotechnology

China Universal Asset Management Co., Ltd.

$1.03 Billion
Q2 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
LGND Ligand Pharmaceuticals Inc	$3.16B	$440,000 0.04% of portfolio	3,875	Q2 2025 Added 0.34%
ARWR Arrowhead Pharmaceuticals, Inc.	$4.49B	$438,000 0.04% of portfolio	27,737	Q2 2025 Added 9.66%
APLS Apellis Pharmaceuticals, Inc.	$2.36B	$436,000 0.04% of portfolio	25,243	Q2 2025 Added 0.27%
VCEL Vericel Corp	$1.63B	$430,000 0.04% of portfolio	10,111	Q2 2025 Added 0.88%
VCYT Veracyte, Inc.	$2.53B	$425,000 0.04% of portfolio	15,729	Q2 2025 Added 0.61%
DNLI Denali Therapeutics Inc.	$2.18B	$408,000 0.04% of portfolio	29,178	Q2 2025 Added 0.17%
ZLAB Zai Lab LTD	$2.56B	$406,000 0.04% of portfolio	11,627	Q2 2025 Reduced 7.31%
RXRX Recursion Pharmaceuticals, Inc.	$1.02B	$406,000 0.04% of portfolio	80,269	Q2 2025 Added 1.29%
AGIO Agios Pharmaceuticals, Inc.	$2.37B	$386,000 0.04% of portfolio	11,632	Q2 2025 Added 1.21%
GMAB Genmab A/S	$18.8B	$380,000 0.04% of portfolio	18,421	Q2 2025 Reduced 60.13%
BCRX Biocryst Pharmaceuticals Inc	$1.36B	$376,000 0.04% of portfolio	42,027	Q2 2025 Added 0.27%
IDYA Ideaya Biosciences, Inc.	$1.52B	$369,000 0.04% of portfolio	17,590	Q2 2025 Added 0.18%
HRMY Harmony Biosciences Holdings, Inc.	$1.69B	$364,000 0.04% of portfolio	11,533	Q2 2025 Added 0.26%
ADPT Adaptive Biotechnologies Corp	$2.42B	$355,000 0.03% of portfolio	30,512	Q2 2025 Added 3.07%
FOLD Amicus Therapeutics, Inc.	$2.53B	$354,000 0.03% of portfolio	61,847	Q2 2025 Added 0.36%
BEAM Beam Therapeutics Inc.	$1.76B	$343,000 0.03% of portfolio	20,197	Q2 2025 Added 18.65%
TARS Tarsus Pharmaceuticals, Inc.	$1.88B	$341,000 0.03% of portfolio	8,438	Q2 2025 Added 9.61%
SRPT Sarepta Therapeutics, Inc.	$2.1B	$337,000 0.03% of portfolio	19,739	Q2 2025 Added 1.42%
ARQT Arcutis Biotherapeutics, Inc.	$1.5B	$335,000 0.03% of portfolio	23,941	Q2 2025 Added 0.61%
VERA Vera Therapeutics, Inc.	$796M	$301,000 0.03% of portfolio	12,809	Q2 2025 Added 0.17%
ETNB 89bio, Inc.	$690M	$287,000 0.03% of portfolio	29,320	Q2 2025 Added 0.13%
EWTX Edgewise Therapeutics, Inc.	$1.16B	$276,000 0.03% of portfolio	21,120	Q2 2025 Added 11.2%
JANX Janux Therapeutics, Inc.	$1.19B	$274,000 0.03% of portfolio	11,885	Q2 2025 Added 0.25%
TVTX Travere Therapeutics, Inc.	$1.9B	$263,000 0.03% of portfolio	17,836	Q2 2025 Added 0.2%
INVA Innoviva, Inc.	$1.25B	$253,000 0.02% of portfolio	12,608	Q2 2025 Added 0.29%
CNTA Centessa Pharmaceuticals PLC	$2.3B	$252,000 0.02% of portfolio	19,181	Q2 2025 Added 4.75%
IMCR Immunocore Holdings PLC	$1.41B	$250,000 0.02% of portfolio	7,982	Q2 2025 Added 0.44%
CVAC Cure Vac N.V.	$1B	$245,000 0.02% of portfolio	45,222	Q2 2025 Added 0.5%
AUPH Aurinia Pharmaceuticals Inc.	$1.72B	$229,000 0.02% of portfolio	27,135	Q2 2025 Reduced 1.5%
MNKD Mannkind Corp	$1.43B	$228,000 0.02% of portfolio	61,044	Q2 2025 Added 0.24%
DYN Dyne Therapeutics, Inc.	$1.17B	$217,000 0.02% of portfolio	22,829	Q2 2025 Added 0.61%
ABCL Ab Cellera Biologics Inc.	$1.58B	$205,000 0.02% of portfolio	59,949	Q2 2025 Added 0.3%
NVAX Novavax Inc	$657M	$204,000 0.02% of portfolio	32,531	Q2 2025 Added 0.83%
VERV Verve Therapeutics, Inc.	$667M	$201,000 0.02% of portfolio	17,904	Q2 2025 Added 0.52%
NTLA Intellia Therapeutics, Inc.	$959M	$195,000 0.02% of portfolio	20,804	Q2 2025 Added 0.19%
ARDX Ardelyx, Inc.	$931M	$188,000 0.02% of portfolio	48,053	Q2 2025 Added 0.51%
GERN Geron Corp	$468M	$180,000 0.02% of portfolio	127,922	Q2 2025 Added 0.13%
NRIX Nurix Therapeutics, Inc.	$603M	$174,000 0.02% of portfolio	15,312	Q2 2025 Added 0.59%
CRMD Cor Medix Inc.	$467M	$167,000 0.02% of portfolio	13,622	Q2 2025 Added 11.92%
COGT Cogent Biosciences, Inc.	$1.07B	$164,000 0.02% of portfolio	22,868	Q2 2025 Added 0.14%
SNDX Syndax Pharmaceuticals Inc	$757M	$161,000 0.02% of portfolio	17,282	Q2 2025 Added 0.94%
AVXL Anavex Life Sciences Corp.	$626M	$158,000 0.02% of portfolio	17,147	Q2 2025 Added 0.5%
QURE Uni Qure N.V.	$3.17B	$153,000 0.01% of portfolio	10,996	Q2 2025 Reduced 4.99%
XERS Xeris Biopharma Holdings, Inc.	$1.33B	$150,000 0.01% of portfolio	32,167	Q2 2025 Added 7.57%
GLUE Monte Rosa Therapeutics, Inc.	$608M	$145,000 0.01% of portfolio	32,354	Q2 2025 Added 162.55%
ORIC Oric Pharmaceuticals, Inc.	$530M	$144,000 0.01% of portfolio	14,278	Q2 2025 Added 0.22%
REPL Replimune Group, Inc.	$505M	$143,000 0.01% of portfolio	15,483	Q2 2025 Added 0.23%
VIR Vir Biotechnology, Inc.	$791M	$139,000 0.01% of portfolio	27,765	Q2 2025 Added 0.93%
PHAT Phathom Pharmaceuticals, Inc.	$542M	$134,000 0.01% of portfolio	14,022	Q2 2025 Added 2.24%
DAWN Day One Biopharmaceuticals, Inc.	$517M	$132,000 0.01% of portfolio	20,358	Q2 2025 Added 0.14%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.